{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T21:25:28Z","timestamp":1787261128507,"version":"build-2736575974"},"reference-count":46,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:00:00Z","timestamp":1785801600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Application of College of American Pathologists (CAP) standards for molecular next-generation sequencing assays, typically high-complexity laboratory-developed tests, requires assay-specific, principled translation. We sought to systematically apply CAP laboratory-developed test validation requirements for next-generating sequencing to targeted CFTR gene sequencing on an Illumina iSeq100 Sequencing System and to address assay-specific translational guidance gaps.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We evaluated the analytic performance (accuracy, precision, analytic sensitivity, and specificity) and other requirements (eg, confirmatory testing, proficiency testing) in a CAP-accredited laboratory, including assessment of logistics (eg, turnaround time, cost), with particular attention to feasibility for smaller laboratories.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Variant calls showed complete concordance across analytic parameters but, as the sole outcome measure, obscured subthreshold effects of experimental variables and random variability. Critical site depth analysis was essential to reveal these effects.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>Per-sample costs depend on batch size; smaller laboratories can reduce costs through centralization or sample pooling, although pooling requires longer turnaround (weeks to months), even on a iSeq100 system, potentially causing misalignment of CAP proficiency testing and batch schedules. This issue mandates self-evaluation and code 11 selection for CAP proficiency testing submissions. Real-time sample preparation, however, precludes running negative and internal controls with each processing run, necessitating process controls (eg, minor allele frequency, alternate allele determination) and an individualized quality control plan.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/labmed\/lmag049","type":"journal-article","created":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T11:41:15Z","timestamp":1784979675000},"source":"Crossref","is-referenced-by-count":0,"title":["Operationalizing accreditation standards for laboratory-developed next-generation sequencing validation of\n                    <i>CFTR<\/i>\n                    amplicon-based assays"],"prefix":"10.1093","volume":"57","author":[{"given":"Muhammad","family":"Fareeduddin","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Indus Hospital & Health Network , Karachi,","place":["Pakistan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Usama","sequence":"additional","affiliation":[{"name":"Molecular Pathology Section, Clinical Laboratories Indus Hospital & Health Network , Karachi,","place":["Pakistan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shakir","family":"Hussain","sequence":"additional","affiliation":[{"name":"Molecular Pathology Section, Clinical Laboratories Indus Hospital & Health Network , Karachi,","place":["Pakistan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rukhsana Syed Aamir","family":"Zahir","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Indus Hospital & Health Network , Karachi,","place":["Pakistan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nada","family":"Sikander","sequence":"additional","affiliation":[{"name":"Clinical Laboratories, Indus Hospital & Health Network , Lahore,","place":["Pakistan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4401-4677","authenticated-orcid":false,"given":"Javeria","family":"Aijaz","sequence":"additional","affiliation":[{"name":"Molecular Pathology Section, Clinical Laboratories Indus Hospital & Health Network , Karachi,","place":["Pakistan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,8,20]]},"reference":[{"key":"2026082016495227300_lmag049-B1","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1146\/annurev.genom.6.080604.162254","article-title":"Modifier genetics: cystic fibrosis","volume":"6","author":"Cutting","year":"2005","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"2026082016495227300_lmag049-B2","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1126\/science.2475911","article-title":"Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA","volume":"245","author":"Riordan","year":"1989","journal-title":"Science"},{"key":"2026082016495227300_lmag049-B3","doi-asserted-by":"publisher","first-page":"e0149426","DOI":"10.1371\/journal.pone.0149426","article-title":"Applicability and efficiency of NGS in routine diagnosis: in-depth performance analysis of a complete workflow for CFTR mutation analysis","volume":"11","author":"Pagin","year":"2016","journal-title":"PLoS One"},{"key":"2026082016495227300_lmag049-B4","doi-asserted-by":"publisher","first-page":"6234","DOI":"10.1038\/s41598-019-42404-6","article-title":"Novel, rare and common pathogenic variants in the CFTR gene screened by high-throughput sequencing technology and predicted by in silico tools","volume":"9","author":"Pereira","year":"2019","journal-title":"Sci Rep"},{"key":"2026082016495227300_lmag049-B5","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/s41434-022-00347-0","article-title":"Splicing mutations in the CFTR gene as therapeutic targets","volume":"29","author":"Deletang","year":"2022","journal-title":"Gene Ther"},{"key":"2026082016495227300_lmag049-B6","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3343\/alm.2021.41.1.25","article-title":"Application of next generation sequencing in laboratory medicine","volume":"41","author":"Zhong","year":"2021","journal-title":"Ann Lab Med"},{"key":"2026082016495227300_lmag049-B7","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1016\/S0140-6736(18)30308-8","article-title":"Laboratory medicine in low-income and middle-income countries: progress and challenges","volume":"391","author":"Nkengasong","year":"2018","journal-title":"Lancet"},{"key":"2026082016495227300_lmag049-B8","doi-asserted-by":"publisher","first-page":"481","DOI":"10.5858\/arpa.2014-0250-CP","article-title":"College of American Pathologists\u2019 laboratory standards for next-generation sequencing clinical tests","volume":"139","author":"Aziz","year":"2015","journal-title":"Arch Pathol Lab Med"},{"key":"2026082016495227300_lmag049-B9","author":"College of American Pathologists","year":"2026"},{"key":"2026082016495227300_lmag049-B10","doi-asserted-by":"publisher","first-page":"958","DOI":"10.5858\/arpa.2015-0507-RA","article-title":"Next-generation sequencing informatics: challenges and strategies for implementation in a clinical environment","volume":"140","author":"Roy","year":"2016","journal-title":"Arch Pathol Lab Med"},{"key":"2026082016495227300_lmag049-B11","doi-asserted-by":"publisher","first-page":"339","DOI":"10.2217\/pme-2016-0104","article-title":"Barriers to clinical adoption of next-generation sequencing: a policy Delphi panel\u2019s solutions","volume":"14","author":"Messner","year":"2017","journal-title":"Per Med"},{"key":"2026082016495227300_lmag049-B12","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.jmoldx.2017.01.011","article-title":"Guidelines for validation of next-generation sequencing-based oncology panels: a joint consensus recommendation of the Association for Molecular Pathology and College of American Pathologists","volume":"19","author":"Jennings","year":"2017","journal-title":"J Mol Diagn"},{"key":"2026082016495227300_lmag049-B13","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.jmoldx.2023.03.012","article-title":"Recommendations for next-generation sequencing germline variant confirmation: a joint report of the Association for Molecular Pathology and National Society of Genetic Counselors","volume":"25","author":"Crooks","year":"2023","journal-title":"J Mol Diagn"},{"key":"2026082016495227300_lmag049-B14","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1038\/s41431-024-01639-2","article-title":"Quality assurance for next-generation sequencing diagnostics of rare neurological diseases in the European Reference Network","volume":"32","author":"Maver","year":"2024","journal-title":"Eur J Hum Genet"},{"key":"2026082016495227300_lmag049-B15","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1038\/nbt.2403","article-title":"Assuring the quality of next-generation sequencing in clinical laboratory practice","volume":"30","author":"Gargis","year":"2012","journal-title":"Nat Biotechnol"},{"key":"2026082016495227300_lmag049-B16","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3201\/eid3113.241175","article-title":"The next-generation sequencing quality initiative and challenges in clinical and public health laboratories","volume":"31","author":"Cherney","year":"2025","journal-title":"Emerg Infect Dis"},{"key":"2026082016495227300_lmag049-B17","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1038\/s41436-020-0822-5","article-title":"CFTR variant testing: a technical standard of the American College of Medical Genetics and Genomics (ACMG)","volume":"22","author":"Deignan","year":"2020","journal-title":"Genet Med"},{"key":"2026082016495227300_lmag049-B18","author":"Clinical and Functional Translation of CFTR (CFTR2)"},{"key":"2026082016495227300_lmag049-B19","first-page":"37","author":"College of American Pathologists","year":"2024"},{"key":"2026082016495227300_lmag049-B20","volume-title":"Next Generation Sequencing (NGS) Worksheets","author":"College of American Pathologists","year":"2023"},{"key":"2026082016495227300_lmag049-B21","author":"Coriell Institute for Medical Research"},{"key":"2026082016495227300_lmag049-B22","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.jmoldx.2017.11.003","article-title":"Standards and guidelines for validating next-generation sequencing bioinformatics pipelines: a joint recommendation of the Association for Molecular Pathology and the College of American Pathologists","volume":"20","author":"Roy","year":"2018","journal-title":"J Mol Diagn"},{"key":"2026082016495227300_lmag049-B23","author":"Clinical and Laboratory Standards Institute (CLSI)","year":"2014"},{"key":"2026082016495227300_lmag049-B24","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1038\/s41436-021-01139-4","article-title":"Next-generation sequencing for constitutional variants in the clinical laboratory, 2021 revision: a technical standard of the American College of Medical Genetics and Genomics (ACMG)","volume":"23","author":"Rehder","year":"2021","journal-title":"Genet Med"},{"key":"2026082016495227300_lmag049-B25","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1038\/gim.2013.92","article-title":"ACMG clinical laboratory standards for next-generation sequencing","volume":"15","author":"Rehm","year":"2013","journal-title":"Genet Med"},{"key":"2026082016495227300_lmag049-B26","doi-asserted-by":"publisher","first-page":"gkaf793","DOI":"10.1093\/nar\/gkaf793","article-title":"Optimal sequencing depth for measuring the concentrations of molecular barcodes","volume":"53","author":"Ocari","year":"2025","journal-title":"Nucleic Acids Res"},{"key":"2026082016495227300_lmag049-B27","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.ajhg.2015.07.002","article-title":"Correcting for sample contamination in genotype calling of DNA sequence data","volume":"97","author":"Flickinger","year":"2015","journal-title":"Am J Hum Genet"},{"key":"2026082016495227300_lmag049-B28","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.1093\/bioinformatics\/btr446","article-title":"ContEst: estimating cross-contamination of human samples in next-generation sequencing data","volume":"27","author":"Cibulskis","year":"2011","journal-title":"Bioinformatics"},{"key":"2026082016495227300_lmag049-B29","author":"Genohub Inc. Illumina iSeQ 100","year":"2024"},{"key":"2026082016495227300_lmag049-B30","doi-asserted-by":"publisher","first-page":"8365","DOI":"10.1038\/s41598-021-87815-6","article-title":"Multiple internal controls enhance reliability for PCR and real time PCR detection of Rathayibacter toxicus","volume":"11","author":"Arif","year":"2021","journal-title":"Sci Rep"},{"key":"2026082016495227300_lmag049-B31","author":"College of American Pathologists","year":"2024"},{"key":"2026082016495227300_lmag049-B32","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.mcp.2015.07.002","article-title":"Quantitative analysis of genomic DNA degradation in whole blood under various storage conditions for molecular diagnostic testing","volume":"29","author":"Permenter","year":"2015","journal-title":"Mol Cell Probes"},{"key":"2026082016495227300_lmag049-B33","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/j.ajhg.2012.09.004","article-title":"Detecting and estimating contamination of human DNA samples in sequencing and array-based genotype data","volume":"91","author":"Jun","year":"2012","journal-title":"Am J Hum Genet"},{"key":"2026082016495227300_lmag049-B34","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3390\/ijns11040091","article-title":"Analytical validation of a genomic newborn screening workflow","volume":"11","author":"Hovhannesyan","year":"2025","journal-title":"Int J Neonatal Screen"},{"key":"2026082016495227300_lmag049-B35","author":"Clinical and Laboratory Standards Institute (CLSI)","year":"2011"},{"key":"2026082016495227300_lmag049-B36","doi-asserted-by":"publisher","first-page":"5697","DOI":"10.1038\/s41598-021-85182-w","article-title":"Sanger sequencing is no longer always necessary based on a single-center validation of 1109 NGS variants in 825 clinical exomes","volume":"11","author":"Arteche-L\u00f3pez","year":"2021","journal-title":"Sci Rep"},{"key":"2026082016495227300_lmag049-B37","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3389\/fgene.2016.00075","article-title":"Integrated systems for NGS data management and analysis: open issues and available solutions","volume":"7","author":"Bianchi","year":"2016","journal-title":"Front Genet"},{"key":"2026082016495227300_lmag049-B38","author":"College of American Pathologists"},{"key":"2026082016495227300_lmag049-B39","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/s41182-025-00797-3","article-title":"A qualitative evaluation of access to essential laboratory services for communicable diseases at the primary health care level in the western Pacific region","volume":"53","author":"Mupunga","year":"2025","journal-title":"Trop Med Health"},{"key":"2026082016495227300_lmag049-B40","author":"Paragon Genomics, Inc","year":"2019"},{"key":"2026082016495227300_lmag049-B41","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.3390\/genes16111375","article-title":"Analysis of human degraded DNA in forensic genetics","volume":"16","author":"Zupani\u010d Pajni\u010d","year":"2025","journal-title":"Genes (Basel)"},{"key":"2026082016495227300_lmag049-B42","doi-asserted-by":"publisher","first-page":"100867","DOI":"10.1016\/j.gim.2023.100867","article-title":"Updated recommendations for CFTR carrier screening: a position statement of the American College of Medical Genetics and Genomics (ACMG)","volume":"25","author":"Deignan","year":"2023","journal-title":"Genet Med"},{"key":"2026082016495227300_lmag049-B43","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1373\/clinchem.2015.249623","article-title":"Systematic evaluation of sanger validation of next-generation sequencing variants","volume":"62","author":"Beck","year":"2016","journal-title":"Clin Chem"},{"key":"2026082016495227300_lmag049-B44","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1186\/s12920-021-01059-x","article-title":"Detecting copy number variation in next generation sequencing data from diagnostic gene panels","volume":"14","author":"Singh","year":"2021","journal-title":"BMC Med Genomics"},{"key":"2026082016495227300_lmag049-B45","doi-asserted-by":"publisher","first-page":"4397","DOI":"10.1093\/bioinformatics\/btz239","article-title":"Structural variant analysis for linked-read sequencing data with gemtools","volume":"35","author":"Greer","year":"2019","journal-title":"Bioinformatics"},{"key":"2026082016495227300_lmag049-B46","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1002\/pd.6027","article-title":"The cost-effectiveness of genotyping versus sequencing for prenatal cystic fibrosis carrier screening","volume":"41","author":"Avram","year":"2021","journal-title":"Prenat Diagn"}],"container-title":["Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/labmed\/article-pdf\/57\/5\/lmag049\/70730602\/lmag049.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/labmed\/article-pdf\/57\/5\/lmag049\/70730602\/lmag049.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T20:50:01Z","timestamp":1787259001000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/labmed\/article\/doi\/10.1093\/labmed\/lmag049\/8767459"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,4]]},"references-count":46,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,8,4]]}},"URL":"https:\/\/doi.org\/10.1093\/labmed\/lmag049","relation":{},"ISSN":["0007-5027","1943-7730"],"issn-type":[{"value":"0007-5027","type":"print"},{"value":"1943-7730","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,9]]},"published":{"date-parts":[[2026,8,4]]},"article-number":"lmag049"}}